Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies

Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies

Nov 25, 2019
|
staff reporter

NEW YORK – Molecular diagnostics company Asuragen announced on Monday that it is collaborating with genetic medicines developer Wave Life Sciences to develop and commercialize companion diagnostics for Wave's investigational allele-selective therapeutic programs for Huntington's disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Circumventing that Pesky Poison

NPR reports that some insect pests are now becoming resistant to Bt crops.

Another Cold Case Arrest

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

Not Convened

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

Nature Papers Describe Future Path for Human Genomic Research, Method to Analyze RNA Structure With Nanopore Sequencing, More

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.

What's Popular?

In Business News

  1. Biocartis, Exact Sciences Terminate Oncotype DX Agreement

  2. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company

  3. Exact Sciences Aiming to Make Pan-Cancer Blood Screening Part of Standard Medical Care

    Premium

  4. PerkinElmer Q3 Revenues Spike 36 Percent

  5. Biodesix Prices $72M IPO

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.